Placental Matrix Therapy

Placental matrix therapy is currently under research for its potential to facilitate tissue regeneration.

What is Placental Matrix Therapy?

Placental Matrix therapy is a research-only treatment at Hudson Medical.  This regenerative procedure administers placental tissue as a replacement for damaged or missing connective tissue.

How Do Placental Matrix Research Procedures Work?

Placental Matrix  research procedures involve replacing damaged connective tissue with an Extracellular Matrix (ECM) derived from a placental source.

The ECM is the interconnected system of collagens, growth factors, and bioactive molecules that provides the structural foundation for our body’s tissues and biochemical support to the surrounding cells.

Placental matrix products are composed of non-immunogenic, multi-potent stem cells that secrete paracrine-acting cytokines and growth factors. It’s also rich in ECM, which serves as an avascular scaffold for tissue development. When these factors are injected into tissue that has been damaged or degraded, they have been shown to rapidly promote healing and tissue regeneration.

What Are the Potential Benefits of Placental Matrix Procedures?

Existing studies indicate that placental matrix procedures may be beneficial to patients because the placental matrix products are non-immunogenic, anti-microbial, and anti-fibrotic.

Because placental tissues are non-immunogenic, they do not typically activate immune responses in the recipient.

These tissues also resist the growth of microorganisms, including bacteria or mold. Anti-microbial properties greatly reduce the risk of disease after placental tissue has been administered.
Placental tissues are known anti-fibrotic materials, meaning fibrosis or scarring is not as likely to form around the placental tissue.

Learn More About Our Placental Matrix Research Initiatives.